Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP PATH extension study

Ivo N. van Schaik*, Orell Mielke, Vera Bril, Nan van Geloven, Hans-Peter Hartung, Richard A. Lewis, Gen Sobue, John-Philip Lawo, Michaela Praus, Billie L. Durn, David R. Cornblath, Ingemar S. J. Merkies, A. Sabet, K. George, L. Roberts, R. Carne, S. Blum, R. Henderson, P. Van Damme, J. DemeestereS. Larue, C. D'Amour, Vera Bril, A. Breiner, P. Kunc, M. Michal, J. Sussova, K. Tomas, R. Talab, B. Michal, T. Toomsoo, Rubanovits, K. Gross-Paju, U. Sorro, M. Saarela, M. Auranen, J. Pouget, S. Attarian, G. Le Masson, A. Wielanek-Bachelet, C. Desnuelle, E. Delmont, P. Clavelou, D. Aufauvre, J. Schmidt, M. Mori, N. Visser, C. Faber, J. Hoeijmakers, PATH Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number590
Number of pages13
JournalNeurology: Neuroimmunology & Neuroinflammation
Volume6
Issue number5
DOIs
Publication statusPublished - Sep 2019

Keywords

  • INFLAMMATORY DEMYELINATING POLYNEUROPATHY
  • MUSCLE STRENGTH
  • MMN

Cite this

van Schaik, I. N., Mielke, O., Bril, V., van Geloven, N., Hartung, H-P., Lewis, R. A., Sobue, G., Lawo, J-P., Praus, M., Durn, B. L., Cornblath, D. R., Merkies, I. S. J., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., ... PATH Study Grp (2019). Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP PATH extension study. Neurology: Neuroimmunology & Neuroinflammation, 6(5), [590]. https://doi.org/10.1212/NXI.0000000000000590